🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

It was a pleasure to meet our colleagues and discuss EORTC ongoing and future breast cancer studies!

On October 31st and November 1st I was in São Paulo (Brazil) to teach the class “Evaluating Magnitude Clinical Benefit: common sense oncology” in the ASCO International Clinical Research (ICR) program. The training was given in person and virtually, in São Paulo (Brazil).

Our #ExecutiveBoard members and #PatientPartners have just arrived in Brussels for a special retreat and to celebrate the 25th anniversary of BIG! 🙌 #BIGagainstbc #EU4Health HaDEA Anticancer Fund

Beautiful event. Happy BIG 25th Anniversary! LACOG - Latin American Cooperative Oncology Group

Gustavo Werutsky, member of BIG #ExecutiveBoard, introduces BIG to Latin American investigators at #SABCS24, fostering global collaboration in #breastcancer #research! 🌎💡 LACOG - Latin American Cooperative Oncology Group SABCS #EU4Health HaDEA

Gustavo Werutsky highlights fast recruitment in global BIG #trials at #SABCS24: #HERA, #APHINITY, and #ALTTO - advancing #breastcancer #research. LACOG - Latin American Cooperative Oncology Group SABCS #EU4Health HaDEA

BIG is reimagining #breastcancer clinical trials with a patient-centric approach! Putting #patient needs at the forefront to drive innovation and improve outcomes. Gustavo Werutsky LACOG - Latin American Cooperative Oncology Group #SABCS24 SABCS #EU4Health HaDEA

#Mindact exploratory analysis showed HER2 low #breastcancer has heterogeneous profile, genomic risk & clinical outcomes. These results may influence future #clinicaltrials with new agents for treatment of #HER2-low early BC #SABCS24 EORTC #EU4Health HaDEA Gustavo Werutsky

So proud of our LATAM hard work. LACOG - Latin American Cooperative Oncology Group Instituto Nacional de Cancerología Gustavo Werutsky Cynthia Villarreal-Garza, MD DSc SAUL CAMPOS GOMEZ

Poster presented at the 2024 SABCS abou the MINDACT trial (EORTC10041 | BIG 03-04), an international study from EORTC and Breast International Group. #SABCS24 #BreastCancer

Poster from the LATINA Breast (LACOG 0615 | MO39485) study sub-analysis presented at the 2024 SABCS. A LACOG - Latin American Cooperative Oncology Group initiative that evaluated the time interval between diagnosis and treatment of early BC and the impact of health insurance coverage in LATAM. #SABCS24

LACOG Educational is a new project by LACOG - Latin American Cooperative Oncology Group. It aims to increase the understanding of methods in clinical trials, cancer translational research and scientific advances in cancer in Latin America. Check out on lacogeducational.com. #LACOG #LACOGEducational

Thrilled to share my OncLive.com interview discussing our #SABCS24 analysis of the MINDACT trial and the prognostic value of MammaPrint in HER2-low early breast cancer. Watch to learn more about this crucial research! EORTC Breast International Group #DrGustavoWerutsky #BreastCancer

In Munich for #ESMObreast25, where new data with potential to change breast cancer care will be presented. It's a key moment to strengthen Latin America's role in global clinical research. ESMO - Eur. Oncology #LACOG #drgustavowerutsky

“Nesta coorte global de portadoras de BRCA com diagnóstico prévio de câncer de mama em idade jovem, a mastectomia redutora de risco e a salpingo-ooforectomia redutora de risco foram associadas a melhora na SG. Leia mais: tinyurl.com/mr2ckuja Gustavo Werutsky Franzoi Maria Alice

At #ESMOBreast2025 following key data that will impact breast cancer care. Productive meetings with international colleagues and LACOG to advance clinical research and bring new therapies to Brazil. LACOG - Latin American Cooperative Oncology Group ESMO - Eur. Oncology #Oncology #BreastCancer #LACOG #ClinicalResearch

Thank you to Dr. Gustavo Werutsky , chair of LACOG - Latin American Cooperative Oncology Group and member of BIG Executive Board, for his commitment to BIG and to #breastcancer research. An important message to close #ESMOBreast25

At ASCO Annual Meeting 2025 (May 30–June 3) in Chicago — the world’s largest oncology conference. Following key research updates and joining LACOG - Latin American Cooperative Oncology Group and Breast International Group meetings to advance collaborative studies for Latin America.

My second year participating in this great meeting. Very interesting topics discussed to build future breast cancer clinical trials with a global collaboration. Breast International Group The Breast Cancer Research Foundation LACOG - Latin American Cooperative Oncology Group National Cancer Institute

The LACOG Scientific Meeting at #ASCO2025 brought together colleagues from across Latin America to discuss ongoing studies and future research in oncology. Thank you to all who joined us in Chicago. LACOG - Latin American Cooperative Oncology Group #LACOG #CancerResearch